Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP492904.RA1MLW0c_6cp9hpDqF5HPQRZqviP7UpC96aWs-ubPy1Nw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP492904.RA1MLW0c_6cp9hpDqF5HPQRZqviP7UpC96aWs-ubPy1Nw130_assertion type Assertion NP492904.RA1MLW0c_6cp9hpDqF5HPQRZqviP7UpC96aWs-ubPy1Nw130_head.
- NP492904.RA1MLW0c_6cp9hpDqF5HPQRZqviP7UpC96aWs-ubPy1Nw130_assertion description "[This study was conducted to test the efficacy of a new cancer vaccine, composed of dendritic cells (DCs) pulsed with an interleukin-2 gene-encoded vaccinia virus tumor oncolysate (DC-IL-2VCO) in a CC-36 murine colon adenocarcinoma model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492904.RA1MLW0c_6cp9hpDqF5HPQRZqviP7UpC96aWs-ubPy1Nw130_provenance.
- NP492904.RA1MLW0c_6cp9hpDqF5HPQRZqviP7UpC96aWs-ubPy1Nw130_assertion evidence source_evidence_literature NP492904.RA1MLW0c_6cp9hpDqF5HPQRZqviP7UpC96aWs-ubPy1Nw130_provenance.
- NP492904.RA1MLW0c_6cp9hpDqF5HPQRZqviP7UpC96aWs-ubPy1Nw130_assertion SIO_000772 17275030 NP492904.RA1MLW0c_6cp9hpDqF5HPQRZqviP7UpC96aWs-ubPy1Nw130_provenance.
- NP492904.RA1MLW0c_6cp9hpDqF5HPQRZqviP7UpC96aWs-ubPy1Nw130_assertion wasDerivedFrom befree-20150227 NP492904.RA1MLW0c_6cp9hpDqF5HPQRZqviP7UpC96aWs-ubPy1Nw130_provenance.
- NP492904.RA1MLW0c_6cp9hpDqF5HPQRZqviP7UpC96aWs-ubPy1Nw130_assertion wasGeneratedBy ECO_0000203 NP492904.RA1MLW0c_6cp9hpDqF5HPQRZqviP7UpC96aWs-ubPy1Nw130_provenance.